Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Stifel Financial Reports Q2 2026 Financial Results

Stifel Financial Corp. filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission, reporting second-quarter and first-half financial results across its brokerage, banking, and advisory operations.

Vinay Lochav | 05 August 2026

Macerich Reports Q2 2026 Results in 10-Q Filing

The Macerich Company (NYSE: MAC) filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the SEC on August 5, 2026, disclosing a net loss attributable to the company of $27,071 thousand for the second quarter and $63,421 thousand …

Aditi Sarkar | 05 August 2026

Clear Secure Reports Q2 2026 Revenue of $277.8 Million

Clear Secure, Inc. filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, covering the three- and six-month periods ended June 30, 2026, disclosing significant revenue growth and net income for both periods.

Aakashdeep | 05 August 2026

NNN REIT Reports Q2 2026 Financial Results

NNN REIT, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the period ended June 30, 2026, disclosing condensed consolidated financial statements and related notes as of that date.

Nitish Kishor | 05 August 2026

CS Disco Reports Q2 2026 Financial Results

CS Disco, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the period ended June 30, 2026.

Anjali Anand | 05 August 2026

Allison Transmission Q2 2026 Quarterly Results Filed

Allison Transmission Holdings, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission, reporting net sales of $1,566 million for the second quarter and disclosing a significant business acquisition completed during the first half …

Aditi Sarkar | 05 August 2026

Royalty Pharma Reports Q2 2026 Financial Results

Royalty Pharma plc filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission on August 5, 2026, reporting total income and other revenues of $674.1 million for the three months ended June 30, 2026.

Manish Choudhary | 05 August 2026

Citigroup Prices Equity-Linked Callable Notes Tied to Three Indexes

Citigroup Global Markets Holdings Inc. filed a 424B2 pricing supplement on August 4, 2026, detailing the terms of Callable Contingent Coupon Equity Linked Securities linked to the worst-performing of the Nasdaq-100 Index, the Russell 2000 Index, and the S&P 500 Index, with a maturity …

Shwetambri Chauhan | 04 August 2026

GATX Corp Senior VP Treasurer Exercises Options and Sells Shares

Jennifer Van Aken, Senior Vice President, Treasurer and Chief Risk Officer of GATX Corp (NYSE: GATX), filed a Form 4 on August 4, 2026, reporting option exercise and open-market share sale transactions dated August 3, 2026.

Nitish Kishor | 04 August 2026

Citigroup Prices Autocallable Index-Linked Notes Due 2031

Citigroup Global Markets Holdings Inc. filed a 424B2 pricing supplement on July 31, 2026, covering the terms of Autocallable Contingent Coupon Equity Linked Securities linked to the worst performing of the Nasdaq-100 Index, the Russell 2000 Index, and the S&P 500 Index, with a …

Vinay Lochav | 04 August 2026
Support

Hi! How can we help you today?

Loading…